Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma

doi:10.3748/wjg.v20.i46.17483

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 46

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6492)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

444

WORD

313

HTML

3339

Figures (1-2)

165

Tables (1-3)

136

Sum=4397

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1035

Download

1060

Sum=2095

Dec 14, 2014 (publication date) through May 9, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Dec 14, 2014; 20(46): 17483-17490
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17483

Open in New Tab Full Size Figure Download Figure

Figure 1 Overall survival curve of 86 patients who underwent transarterial chemoembolization-microwave ablation. TACE: Transarterial chemoembolization; MWA: Microwave ablation.

Open in New Tab Full Size Figure Download Figure

Figure 2 Survival curves of 86 patients with different prognostic factors. A: Patients with different sizes of hepatocellular carcinoma (HCC); B: Patients with different stages of Barcelona Clinic Liver Cancer; C: Patients with different types of portal vein tumor thrombus; D: Patients with different times of microwave ablation treatment; E: Patients with different Eastern Cooperative Oncology Group scores; F: Patients with and without therapy with targeted drugs.

Citation: Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma. World J Gastroenterol 2014; 20(46): 17483-17490
URL: https://www.wjgnet.com/1007-9327/full/v20/i46/17483.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i46.17483